4Faergemann J, Jones JC, Hettler O, et al. Pityrosporum ovale ( Malassezia furfur)as the causative agent of seborrhoeic dermatitis:new treatment options[ J]. Br J Dermatol, 1996,134 (Suppl 46 ) :12-15.
二级参考文献24
11，Roberts DT. Terbinafine in the treatment of onychomycosis. J Dermatol Treat, 1998,9(suppl 1):3～8
22，Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmokinetic properties, and therapeutic potential in superficial mycoses. Drugs, 1992,43(2):259～284
33，Jones TC. Treatment of dermatomycoses with topically applied allyamines: naftifine and terbinafine. J Dermatol Treat, 1990,1(suppl 2):29～32
44，Faergemann J. Pityrosporum ovale(Malassezia ferfer) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol, 1996,134(suppl 46):12～15
55，Faergemann J, Hersle K, Nordin P. Pityriasis versicolor: clinical experience with lamisil cream and lamisil dermgel. Dermatology, 1997,194(suppl 1):19～21
66，Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involovement by non-dermatophytic fungi. Br J Dermatol, 1994,130(suppl 43):16～21
77，Segal R. Treatment of Candida nail infection with terbinafine. J Am Acad Dermatol, 1996,35(2):958～961
88，Nandwani R. Use of terbinafine in HIV-possitive subjests: pilot studies in onychomycosis and oral candidiasis. Br J Dermatol, 1996,134(suppl 46):22～24
99，Esterre P. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol, 1996,134(suppl 46):33～36
1010，Esterre P,Inzan CK, Ratsioharana M, et al. A multicentre trial of terbinafine in patients with chromoblastomycosis: effect on clinical and biological criteria.J Dermatol Treat, 1998,9(suppl 1):29～34
